ProShare Advisors LLC reduced its stake in shares of Masimo Corporation (NASDAQ:MASI) by 15.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,109 shares of the medical equipment provider’s stock after selling 1,309 shares during the quarter. ProShare Advisors LLC’s holdings in Masimo Corporation were worth $648,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Prudential Financial Inc. boosted its position in Masimo Corporation by 14.4% during the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock valued at $50,442,000 after purchasing an additional 69,810 shares in the last quarter. American Century Companies Inc. grew its stake in Masimo Corporation by 98.0% in the second quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock valued at $19,100,000 after purchasing an additional 103,656 shares during the last quarter. D L Carlson Investment Group Inc. grew its stake in Masimo Corporation by 32.4% in the second quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock valued at $4,216,000 after purchasing an additional 11,315 shares during the last quarter. Robeco Institutional Asset Management B.V. grew its stake in Masimo Corporation by 27.1% in the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after purchasing an additional 233,412 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock valued at $42,466,000 after purchasing an additional 45,833 shares during the last quarter. Hedge funds and other institutional investors own 83.21% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/proshare-advisors-llc-has-648000-position-in-masimo-corporation-masi/1606977.html.

In related news, insider Jon Coleman sold 25,000 shares of the business’s stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares in the company, valued at $3,139,597.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Sanford Fitch sold 6,000 shares of the business’s stock in a transaction on Thursday, July 13th. The stock was sold at an average price of $91.89, for a total transaction of $551,340.00. Following the transaction, the director now owns 89,249 shares of the company’s stock, valued at approximately $8,201,090.61. The disclosure for this sale can be found here. Over the last three months, insiders sold 112,000 shares of company stock worth $10,444,090. Insiders own 16.60% of the company’s stock.

Masimo Corporation (NASDAQ MASI) opened at 85.45 on Wednesday. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of 14.01 and a beta of 0.82. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The company’s 50-day moving average price is $85.28 and its 200 day moving average price is $90.28.

Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same quarter in the previous year, the firm earned $0.57 earnings per share. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. Analysts predict that Masimo Corporation will post $2.80 EPS for the current year.

Several analysts have commented on the stock. Zacks Investment Research lowered shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 4th. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research report on Monday, August 14th. Finally, Stifel Nicolaus initiated coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price objective for the company. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $95.00.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.